Clinical Trial Update: A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing taspoglutide with sitagliptin in adults with Type 2 diabetes mellitus inadequately controlled with metformin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)
• Taspoglutide (taspoglutide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 3 | Status: COMPLETED